Table 2.
Disease | Current strategy | Key elimination strategies | Programmatic considerations |
---|---|---|---|
Soil-transmitted helminthiasis [40] | MDA to school-aged children and high-risk subgroups | • Community-wide MDA in all but low-prevalence settings • No reduction in treatment frequency at the midline evaluation point due to the risk of recrudescence and failure to meet morbidity goal |
• Cost of expanding the treated population • Restriction of drug donations to SAC • Unknown risk of drug resistance |
Schistosomiasis [41] | MDA to school-aged children and high-risk subgroups. | • Increasing treatment coverage in school-aged children and expanding treatment coverage to include adults • Or increasing treatment frequency in moderate- to high-prevalence regions. |
• Cost of expanding the treated population • Restriction of drug donations to use in school- aged children and availability of praziquantel • Difficulties assessing adherence to treatment • Defining the optimal strategy for tailoring the intervention to infection prevalence |
Lymphatic filariasis [43] | MDA of all eligible persons | • Increasing coverage and reducing systematic nonadherence• Using the triple-drug to accelerate declines in appropriate areas | • Addressing systematic nonadherence• Availability of drug donations for triple-drug |
Onchocerciasis [44] | Annual MDA with ivermectin of population aged 5 years | • Alternative MDA strategies (enhanced coverage, increased frequency), with or without complementary vector control, depending on history of MDA and local transmission conditions (or baseline endemicity) | • Vector control is laborious but could have benefits • Need for in-depth knowledge of vector breeding site ecology and hydrological conditions in rivers to be treated with larvicides for vector control • Cost and appropriate and timely implementation of higher frequency MDA programs in low-resources settings |
Trachoma [45] | Annual MDA of all individuals | • In areas that have not reached control goals after a decade of treatment, intensive targeting of residual core group • Investigating coverage |
• Identification of areas where current strategy is not working • Efficient assessment and treatment of residual core group |
Abbreviations: MDA, mass drug administration; SAC, school-aged children.